
pmid: 15970315
The present study in mice compared the putative anxiolytic-like effect of paeonol, a phenolic component from the root bark of Paeonia moutan, with the benzodiazepine diazepam in the elevated plus maze and the light/dark box-test. The comparison was also with regard to locomotor activity (open-field test) and myorelaxant potential (inclined plane test). As with 2 mg/kg diazepam, paeonol (at 17.5 mg/kg) increased the percentage of time spent on open arms in the elevated plus maze and increased the time spent in the light area of the light/dark box (at 8.75 and 17.5 mg/kg). Since paeonol, in contrast to diazepam, had no effect on either the number of squares entered in the open-field test or in the inclined plane test, its side-effect profile is considered as superior to the benzodiazepine.
Male, Analysis of Variance, Diazepam, Behavior, Animal, Dose-Response Relationship, Drug, Light, Muscle Relaxants, Central, Acetophenones, Darkness, Motor Activity, Mice, Anti-Anxiety Agents, Animals, Maze Learning
Male, Analysis of Variance, Diazepam, Behavior, Animal, Dose-Response Relationship, Drug, Light, Muscle Relaxants, Central, Acetophenones, Darkness, Motor Activity, Mice, Anti-Anxiety Agents, Animals, Maze Learning
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 69 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
